Opendata, web and dolomites

LIPOCOAT SIGNED

Biomimetic nano-coatings for healthcare. Targeting the contact lenses market

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 LIPOCOAT project word cloud

Explore the words cloud of the LIPOCOAT project. It provides you a very rough idea of what is the project "LIPOCOAT" about.

proteins    recovered    bodily    molecules    biomedical    sales    nano    10    32    manufacturing    vivo    device    adhesion    lipid    inspired    attract    decided    estimates    bacterial    launching    comfort    biocompatible       commercialization    patented    bio    million    found    time    body    performance    fast    2020    95    neutral    2014    lenses    cumulative    first    initial    flow    cell    efficiency    lipocoat    cagr    business    close    cells    ties    commercial    international    billion    market    investment    coatings    benefits    opportunity    demo    fluids    outside    vitro    biofouling    bacteria    extremely    wetting    forecast    placed    national    clear    demonstrated    deposits    interaction    stably    global    view    water    projected    prevent    medical    contact    roi    lubricity    cls    bilayers    11    fifth    16    improvement    natural    preventing    surface    biomolecules    industrialization    proprietary    cash    manufacturers    coating    layers    2019   

Project "LIPOCOAT" data sheet

The following table provides information about the project.

Coordinator
LIPOCOAT BV 

Organization address
address: DRIENERLOLAAN 5
city: ENSCHEDE
postcode: 7522 NB
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Netherlands [NL]
 Project website http://www.lipocoat.com
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-03-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    LIPOCOAT BV NL (ENSCHEDE) coordinator 50˙000.00

Map

 Project objective

Biofouling, i.e. the formation of deposits of biomolecules or even bacteria in the surface of the medical device, is the main cause of the loss of the devices performance. LipoCoat’s patented nano-coatings make use of lipid bilayers to prevent biofouling of medical devices when placed into contact with bodily fluids in- or outside of the body. Our natural and bio-inspired coating makes use of molecules found in every cell, making it extremely biocompatible. The neutral LipoCoat molecules can efficiently attract water thus preventing any interaction with proteins and cells. Furthermore, LipoCoat can stably apply these layers using our proprietary LipoCoat FAST manufacturing process. Among the wide range of biomedical applications for LipoCoat nano-coatings, we decided to target the contact lenses as it presents a clear business opportunity (a € 11.4 billion global market with a projected CAGR of 7-10% 2014-2019). Demo studies, both in vitro and in vivo, have demonstrated the LipoCoat coating efficiency and its benefits on contact lenses: 95% reduction in bacterial adhesion, improved wetting and lubricity and comfort improvement. In view of these promising results, we were able to establish close ties with leading national and international CLs manufacturers.

The next step for LipoCoat’s commercial success on the contact lenses market, which comprises the main objective of this project, is the industrialization of our proprietary manufacturing process to scale-up the production of LipoCoat nano-coatings. We expect a time-to-market of 2 years, launching our product on the CLs market by 2020. Our initial sales forecast estimates a cumulative cash flow of € 32.2 million after the five first years of commercialization. The estimated investment needed, € 2 million, will be recovered after only two years, and the estimated ROI after the fifth commercialization year is 16.2%.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "LIPOCOAT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "LIPOCOAT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)

SUPPLEPRINT (2018)

Super Productive Line Printing Inkjet

Read More  

Gri3D (2018)

The industrialization and market entry of a novel bioengineered hydrogel grid to standardize stem cell cultures for precision medicine.

Read More  

CGM (2018)

A next generation nano media tailored to capture and recycle hazardous micropollutants in contaminated industrial wastewater.

Read More